TULUA Male High-Definition Abdominoplasty.

BACKGROUND: Abdominoplasty is a surgical technique for body contouring that has been shown to improve the patient's quality of life. It has become more common among male patients, so clear differences between procedures for men and women have to be stated. The authors present their experience with high-definition lipoabdominoplasty with transverse plication in men. METHODS: Records of male patients undergoing transverse plication full abdominoplasty in addition to high-definition liposculpture were analyzed. A total of 24 consecutive cases were found between January of 2017 and June of 2019. Patient ages ranged from 24 to 60 years. Patients aged 18 years or younger were excluded. Body mass index ranged from 25 to 33 kg/m2. Photographic records were taken before and during follow-up at 2 days and 1, 3, 6, and 12 months after surgery. RESULTS: Male TULUA (transverse plication, no undermining, full liposuction, neoumbilicoplasty, and low transverse abdominal scar) with high-definition lipoabdominoplasty was successfully achieved in 24 cases. No major complications were reported. Six minor complications were reported (25 percent). Rectus abdominis diastases are less common in men compared to women, as pregnancy is the most determining factor in its development. Fat distribution is also a key difference when performing lipoabdominoplasty for the male or the female patient. The authors recommend a transverse plication of the abdominal wall, instead of a vertical one, as flap viability is preserved and enhanced muscular definition can be accomplished. CONCLUSIONS: Combining transverse plication with high-definition lipoabdominoplasty (transverse plication, no undermining, full liposuction, neoumbilicoplasty, and low transverse abdominal scar plus high-definition lipoabdominoplasty) is a safe and reproducible technique for the male patient. It offers higher aesthetic results in line with modern beauty ideals. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

A novel approach to abdominoplasty: TULUA modifications (transverse plication, no undermining, full liposuction, neoumbilicoplasty, and low transverse abdominal scar).

BACKGROUND: Lipoabdominoplasty can be associated with complications, particularly tissue necrosis, wound dehiscence, epigastric bulging, high transverse scar, low positioning of the umbilicus, and seroma. METHODS: Modified abdominoplasty characterized by (1) transverse elliptical plication of the lower abdominal wall, (2) no undermining of the flap above the navel, (3) unrestricted liposuction, (4) umbilical amputation and neoumbilicoplasty by skin graft, and (5) low transversely placed abdominal scar (TULUA) was performed for 42 patients. These procedures were elective and performed primarily to remedy epigastric skin redundancy associated with obesity or when supraumbilical undermining was considered inappropriate. RESULTS: The results were objectively scored as excellent for 20 patients, good for 21 patients, and fair for 1 patient. A normal-appearing umbilicus was attained in all cases except one. The lower transverse scars were generally concealable (6.3 ± 1.4 cm from the anterior vulvar commissure), and epigastric bulging was avoided. Although four patients experienced seromas at the tail ends of incisions, no skin necrosis, wound dehiscence, or other major complications such as venothromboembolism occurred, and there were no fatalities. In four patients, postoperative magnetic resonance imaging demonstrated measurable and significant changes attributable to plicature compared with equivalent control points (p < 0.000001), which persisted over time. CONCLUSIONS: The TULUA procedure offers potential advantages in terms of vascular safety, sensory recovery, position and quality of the umbilicus, and transverse scar location, with aesthetic outcomes that generally eliminate epigastric bulging. A sizeable patient population stands to benefit from this approach, especially when obesity, smoking, secondary revisions, umbilical or hypogastric hernias, and massive weight loss are clinical considerations for abdominoplasty. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.

[The role of depression in the quality of life among patients undergoing renal substitutive therapy]. / Calidad de vida relacionada con la salud en los pacientes con tratamiento sustitutivo renal: el papel de la depresión.

BACKGROUND: Depression is highly prevalent among patients with end-stage renal disease, nevertheless few patients are assessed or offered medical treatment to minimize its effects. This study assessed quality of life among these patients and studied the association between end-stage renal disease and depression. MATERIAL AND METHODS: We carried out a cross-sectional study with 123 patients over 19 who were undergoing renal substitutive therapy. Quality of life and depression were assessed using the Kidney Disease Quality of Life Short Form-36 and the Beck Depression Inventor. In order to measure the patients' metabolic state, we carried out medical and laboratory tests. Quality of life predictors were analyzed with multiple ordinal logistic regression models. RESULTS: The highest scores from the generic core belonged to social functioning dimensions (62.7) and mental health (65.9). For the specific core, the highest scores were in dimensions associated with support offered by the dialysis team (78.2) and from social support networks (75.3). Depression was the most consistent predictor of quality of life. CONCLUSION: The use of programs and measuring tools to measure quality of life prior to and during renal dialysis or hemodialysis, as well as a timely psychiatric evaluation, can be very useful in monitoring improvement, decline and response to anti-depressant treatment throughout the course of end-stage renal disease.

Calidad de vida relacionada con la salud en los pacientes con tratamiento sustitutivo renal: el papel de la depresión / The role of depression in the quality of life among patients undergoing renal substitutive therapy

Antecedentes: La depresión está bien identificada entre pacientes con enfermedad renal terminal, sin embargo, pocos pacientes reciben evaluación o terapia médica para minimizar los efectos de este trastorno. Nuestro estudio evalúa la calidad de vida de estos pacientes y su relación con depresión. Material y métodos: Se realizó un estudio transversal en 123 pacientes mayores de 19 años de edad con tratamiento sustitutivo renal. La calidad de vida y la depresión se evaluaron mediante los cuestionarios de calidad de vida en enfermedad renal versión 1.3 (KDQOL SF-36) y el inventario de depresión de Beck. El estado metabólico se determinó mediante estudios de laboratorio. Los predictores de calidad de vida se estimaron mediante modelos múltiples de regresión logística ordinal. Resultados: En el módulo genérico del instrumento de calidad de vida, las calificaciones más altas correspondieron a las dimensiones de función social (62.7) y salud mental (65.9), mientras que para el módulo específico correspondieron a apoyo del equipo de diálisis (78.2) y apoyo social (75.3). El predictor de calidad de vida más consistente fue depresión. Conclusiones: La medición de calidad de vida, antes y después de la terapia dialítica, y la evaluación psiquiátrica temprana pueden ser muy útiles para monitoreo del mejoramiento, del deterioro y la respuesta al tratamiento antidepresivo durante la evolución de la insuficiencia renal terminal.

BACKGROUND: Depression is highly prevalent among patients with end-stage renal disease, nevertheless few patients are assessed or offered medical treatment to minimize its effects. This study assessed quality of life among these patients and studied the association between end-stage renal disease and depression. MATERIAL AND METHODS: We carried out a cross-sectional study with 123 patients over 19 who were undergoing renal substitutive therapy. Quality of life and depression were assessed using the Kidney Disease Quality of Life Short Form-36 and the Beck Depression Inventor. In order to measure the patients' metabolic state, we carried out medical and laboratory tests. Quality of life predictors were analyzed with multiple ordinal logistic regression models. RESULTS: The highest scores from the generic core belonged to social functioning dimensions (62.7) and mental health (65.9). For the specific core, the highest scores were in dimensions associated with support offered by the dialysis team (78.2) and from social support networks (75.3). Depression was the most consistent predictor of quality of life. CONCLUSION: The use of programs and measuring tools to measure quality of life prior to and during renal dialysis or hemodialysis, as well as a timely psychiatric evaluation, can be very useful in monitoring improvement, decline and response to anti-depressant treatment throughout the course of end-stage renal disease.